Resources

Evidence & guidelines-based application of PGx in mental health

Learn how evidence and guidelines-based pharmacogenomics (PGx) can be a useful tool to inform medication selection and dosing in psychiatry.

Speakers: Dr. Jon Durrani
Practicing Neurologist, Dayton Center for Neurological Disorders

Dr. Muneer Ali
Child, Adolescent and Adult Psychiatrist & Senior Director of Medical Affairs, Neuro/Psychiatry, Tempus

Watch replay

The evolving landscape in precision oncology: key research findings from the 2023 ASCO Annual Meeting

Hear from Tempus moderators Dr. Ezra Cohen and Dr. Calvin Chao as they engage in a multi-disciplinary discussion around practice changing approaches to somatic and germline testing with Dr. Ramaswamy Govindan from Siteman Cancer Center and Dr. Cathy Handy Marshall from Johns Hopkins Medicine.

Speakers: Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus

Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus

Dr. Ramaswamy Govindan
Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

Catherine Handy Marshall, MD, MPH
Assistant Professor of Oncology, Johns Hopkins Medicine

Watch replay

An analysis on the utility of liquid biopsy (LBx) throughout clinical development

Listen to industry leaders discuss longitudinal endpoints for disease progression, the evolving role of liquid biopsy within drug development, and the value of methylation in combination with liquid biopsy.

Speakers: Nike Beaubier, MD
Senior Vice President, Life Science Pathology, Tempus

Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus

Michael Yasiejko
General Manager and Executive Vice President, Tempus

Watch replay

Accelerate clinical trial enrollment and site activation

Learn how TriHealth uses the TIME network to identify trial subjects and rapidly activate new clinical trials within its oncology portfolio within an average of ~10 business days.

Speakers: Amy Gordon Franzen
SVP, Trials Business, Tempus

James F Maher, MD
Oncologist, TriHealth

Jason Claes, MBA, MSM, GRCRA
Clinical Research Manager, TriHealth

Watch replay

Tempus’ FDA approval and insights on the use of companion diagnostics in clinical development

Tempus has recently announced the PMA approval for xT CDx, our solid tumor CDx and 648 gene panel.

Speakers: Elaine Katrivanos
VP, Regulatory Affairs, Tempus

Lauren Silvis
SVP, External Affairs, Tempus

Kate Sasser
Chief Scientific Officer, Tempus

Watch replay

NGS in advanced breast cancer: exploring recent clinical advancements

Learn more about breast cancer management with NGS. We explore the potential utility of complementary solid tumor and liquid biopsy testing in informing treatment decisions, as well as patient management strategies in the post CDK4/6 inhibitor therapy setting.

Speakers: Calvin Chao, MD
SVP of Medical Affairs, Tempus

Cynthia Ma, MD, PhD
Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

Massimo Cristofanilli, MD, FACP
Chief, Breast Medical Oncology, Sandra Edward Meyer Cancer Center at Weill Cornell Medicine

Watch replay

Increasing PTS using multimodal data

Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.

Speakers: Iker Huerga
SVP, Life Sciences Strategy, Tempus

Leora Horn, MD
Global Clinical Head for Lung Cancer & Lung Cancer Strategy, AstraZeneca

Watch replay

Multimodal data drives biomarker innovation

We spoke with Gilead experts to learn how the company uses multimodal data to achieve early successes in translational biomarker research and discovery.

Speakers: Ryan Fukushima
Chief Operating Officer, Tempus

Scott Patterson, PhD
Vice President of Biomarker Sciences, Gilead Sciences, Inc.

Shahed Iqbal, PhD
Senior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc.

Watch replay

The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting

Speakers: Ezra Cohen, MD, FRCPSC, FASCO
Chief, Division of Hematology-Oncology, UC San Diego Moores Cancer Center

Mary J. Fidler, MD
Medical Oncology Section Chief, Rush Medical Center

Wade T. Iams, MD, MSCI
Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center

Calvin Chao, MD
SVP, Medical Affairs, Tempus

James L. Chen, MD
SVP, Cancer Informatics, Tempus

Watch replay

Personalize mental health with Pharmacogenomics

In this on-demand webinar, Dr. Brian Forsythe shares how he incorporates PGx testing into clinical practice to inform treatment decisions for patients.

Speakers: Brian C. Forsythe, D.O.; Dallas Psychiatry & TMS Center, Joseph D. Stanton, PhD - Associate Director, Medical Affairs

Watch replay